Surface Oncology

+$0.26 (+3.59%) Today
-$0.06 (-0.80%) As of 10:12 AM UTC after-hours

Why Robinhood?

You can buy or sell SURF and other stocks, options, and ETFs commission-free!

About SURF

Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company. It focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies.

CEO
Robert W. Ross
Employees
51
Headquarters
Cambridge, Massachusetts
Founded
2014

SURF Key Statistics

Market Cap
329.70M
Price-Earnings Ratio
4.66
Dividend Yield
—
Average Volume
1.14M
High Today
$7.52
Low Today
$6.96
Open Price
$7.30
Volume
1.63M
52 Week High
$14.40
52 Week Low
$2.39

SURF Earnings

-$0.61
$0.11
$0.84
$1.56
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.30 per share
Actual
-$0.37 per share

You May Also Like

CRZBY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure